IRLAB Therapeutics AB (publ) IRLAB-A.ST Stock
13.7 SEK
{{ price }}
0.735290%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
710.6M SEK
LOW - HIGH [24H]
13.65
-
13.95 SEK
VOLUME [24H]
863 SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-3.03 SEK
IRLAB Therapeutics AB (publ) Price Chart
IRLAB Therapeutics AB (publ) IRLAB-A.ST Financial and Trading Overview
| IRLAB Therapeutics AB (publ) stock price | 13.7 SEK |
| Previous Close | 7.72 SEK |
| Open | 7.92 SEK |
| Bid | 7.6 SEK x 0 |
| Ask | 7.84 SEK x 0 |
| Day's Range | 7.5 - 7.96 SEK |
| 52 Week Range | 6.6 - 42.1 SEK |
| Volume | 2.32K SEK |
| Avg. Volume | 35.5K SEK |
| Market Cap | 406.65M SEK |
| Beta (5Y Monthly) | 0.359386 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.03 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 32 SEK |
IRLAB-A.ST Valuation Measures
| Enterprise Value | 203.79M SEK |
| Trailing P/E | N/A |
| Forward P/E | -2.473186 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.806048 |
| Price/Book (mrq) | 1.7582418 |
| Enterprise Value/Revenue | 3.912 |
| Enterprise Value/EBITDA | -1.47 |
Trading Information
IRLAB Therapeutics AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.359386 |
| 52-Week Change | -78.43% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 42.1 SEK |
| 52 Week Low | 6.6 SEK |
| 50-Day Moving Average | 9.87 SEK |
| 200-Day Moving Average | 22.96 SEK |
IRLAB-A.ST Share Statistics
| Avg. Volume (3 month) | 35.5K SEK |
| Avg. Daily Volume (10-Days) | 21.76K SEK |
| Shares Outstanding | 51.79M |
| Float | 35.46M |
| Short Ratio | N/A |
| % Held by Insiders | 42.13% |
| % Held by Institutions | 21.48% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -276.023% |
| Operating Margin (ttm) | -275.52% |
| Gross Margin | -160.72% |
| EBITDA Margin | -266.084% |
Management Effectiveness
| Return on Assets (ttm) | -25.18% |
| Return on Equity (ttm) | -47.80% |
Income Statement
| Revenue (ttm) | 52.09M SEK |
| Revenue Per Share (ttm) | 1.01 SEK |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -64770000 SEK |
| EBITDA | -138614000 SEK |
| Net Income Avi to Common (ttm) | -143792000 SEK |
| Diluted EPS (ttm) | -2.74 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 210.1M SEK |
| Total Cash Per Share (mrq) | 4.05 SEK |
| Total Debt (mrq) | 3.09M SEK |
| Total Debt/Equity (mrq) | 1.34 SEK |
| Current Ratio (mrq) | 4.87 |
| Book Value Per Share (mrq) | 4.459 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -151327008 SEK |
| Levered Free Cash Flow (ttm) | -100751752 SEK |
Profile of IRLAB Therapeutics AB (publ)
| Country | Sweden |
| State | N/A |
| City | Gothenburg |
| Address | Arvid Wallgrens Backe 20 |
| ZIP | 413 46 |
| Phone | 46 3 17 57 38 00 |
| Website | https://www.irlab.se |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 31 |
IRLAB Therapeutics AB (publ) develops drugs for the treatment of Parkinson's disease. The company develops Mesdopetam that is in phase IIb/III clinical studies for the treatment of dyskinesia; and Pirepemat, which is in phase IIb clinical trial for the treatment of Postural dysfunction. Its preclinical stage products include IRL942 research programs for the treatment of neurodegenerative disorders and ageing; IRL1117, a drug candidate developed for once-daily oral treatment for the hallmark symptoms of Parkinson's; and IRL757 to treat apathy in neurological diseases. In addition, the company develops P003, a research project that develops drugs for the treatment of newly diagnosed Parkinson's disease. IRLAB Therapeutics AB (publ) was incorporated in 2013 and is headquartered in Gothenburg, Sweden.
Q&A For IRLAB Therapeutics AB (publ) Stock
What is a current IRLAB-A.ST stock price?
IRLAB Therapeutics AB (publ) IRLAB-A.ST stock price today per share is 13.7 SEK.
How to purchase IRLAB Therapeutics AB (publ) stock?
You can buy IRLAB-A.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IRLAB Therapeutics AB (publ)?
The stock symbol or ticker of IRLAB Therapeutics AB (publ) is IRLAB-A.ST.
Which industry does the IRLAB Therapeutics AB (publ) company belong to?
The IRLAB Therapeutics AB (publ) industry is Biotechnology.
How many shares does IRLAB Therapeutics AB (publ) have in circulation?
The max supply of IRLAB Therapeutics AB (publ) shares is 51.87M.
What is IRLAB Therapeutics AB (publ) Price to Earnings Ratio (PE Ratio)?
IRLAB Therapeutics AB (publ) PE Ratio is now.
What was IRLAB Therapeutics AB (publ) earnings per share over the trailing 12 months (TTM)?
IRLAB Therapeutics AB (publ) EPS is -3.03 SEK over the trailing 12 months.
Which sector does the IRLAB Therapeutics AB (publ) company belong to?
The IRLAB Therapeutics AB (publ) sector is Healthcare.
IRLAB Therapeutics AB (publ) IRLAB-A.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX Stockholm Pharmaceuticals a SX201030GI | 7742.42 SEK 755.76 USD |
+0.01
|
— — | — — | — — | — - | — — |
| OMX_Stockholm_Mid_Cap_PI OMXSMCPI | 1655.29 SEK 161.58 USD |
-0.06
|
— — | 1652.6 SEK 161.31 USD | 1660.46 SEK 162.08 USD | — - | — — |
| OMX Stockholm_GI OMXSGI | 484.85 SEK 47.33 USD |
+0.39
|
— — | 484.19 SEK 47.26 USD | 486.31 SEK 47.47 USD | — - | — — |
| OMX_Nordic_Mid_Cap_SEK_GI OMXNMCSEKGI | 576.81 SEK 56.3 USD |
+0.26
|
— — | 574.63 SEK 56.09 USD | 577.75 SEK 56.4 USD | — - | — — |
| OMX_Nordic_Mid_Cap_EUR_GI OMXNMCEURGI | 474.96 EUR 519.2 USD |
+0.29
|
— — | 473.44 EUR 517.53 USD | 476.07 EUR 520.41 USD | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 949.8 SEK 92.71 USD |
+0.23
|
— — | 949.8 SEK 92.71 USD | 954.17 SEK 93.14 USD | — - | — — |
| OMX Stockholm Health Care PI SX20PI | 3541.33 SEK 345.68 USD |
-0.34
|
— — | 3541.33 SEK 345.68 USD | 3577.03 SEK 349.16 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5704.1 SEK 556.79 USD |
0
|
— — | 5704.1 SEK 556.79 USD | 5704.1 SEK 556.79 USD | — - | — — |
| OMX Stockholm_PI OMXSPI | 973.94 SEK 95.07 USD |
+0.24
|
— — | 973.94 SEK 95.07 USD | 978.33 SEK 95.5 USD | — - | — — |
| OMX_Stockholm_Mid_Cap_GI OMXSMCGI | 879.43 SEK 85.84 USD |
-0.06
|
— — | 878 SEK 85.7 USD | 882.18 SEK 86.11 USD | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 473.74 SEK 46.24 USD |
+0.14
|
— — | 473.74 SEK 46.24 USD | 476.32 SEK 46.49 USD | — - | — — |
| OMX_Nordic_Mid_Cap_ISK_GI OMXNMCISKGI | 668.68 ISK 4.92 USD |
+0.43
|
— — | 666.53 ISK 4.9 USD | 670.32 ISK 4.93 USD | — - | — — |
| OMX_Nordic_Mid_Cap_DKK_GI OMXNMCDKKGI | 475.15 DKK 69.67 USD |
+0.29
|
— — | 473.62 DKK 69.44 USD | 476.26 DKK 69.83 USD | — - | — — |
| OMX Stockholm Health Care GI SX20GI | 4562.67 SEK 445.37 USD |
-0.62
|
— — | 4562.67 SEK 445.37 USD | 4584.44 SEK 447.5 USD | — - | — — |
- {{ link.label }} {{link}}